• IPS

  • Menu
  • HOME
  • ABOUT
  • TESTING SERVICES
  • MEDIA ROOM
    • NEWS
    • EVENTS
    • VIDEOS
  • COLLABORATIONS
  • CAREERS
  • CONTACT US
  • 12 Sep 2022

    Nanomix Enters into Distribution Agreement for the eLab System and Future N ...

  • 22 Apr 2020

    Caris Life Sciences Launches Whole Exome Sequencing with MI Exome

  • 31 Mar 2020

    Caris Life Sciences Launches MI FOLFOXai, Improving Overall Survival by 50% ...

  • 27 Feb 2020

    Inivata’s Nitzan Rosenfeld to Receive 2020 Cancer Researcher Award from the ...

  • 20 Jan 2020

    NCCN Stresses the Importance of RNA Sequencing in Updated NSCLC Guidelines

  • 11 Dec 2019

    Caris Life Sciences Launches First Ever Molecular AI Product: A Clinical Ge ...

  • 10 Dec 2019

    Caris Life Sciences to Present Data Evaluating PI3K Pathway Alterations at ...

  • 4 Dec 2019

    Caris Life Sciences and Ambry Genetics Partner to Advance Cancer Care

  • 29 Oct 2019

    Inivata and the European Organization for Research and Treatment of Cancer ...

  • 19 Sep 2019

    Caris Life Sciences to Present New Research Across Tumor Types at ESMO Cong ...

  • 29 Aug 2019

    Inivata to Present New Clinical Data on the Utility of Liquid Biopsy and In ...

  • 26 Aug 2019

    MDxHealth Announces Favorable Draft Medicare Coverage for the SelectMDx Tes ...

  • 20 Aug 2019

    Caris Life Sciences Accelerates Growth Through Development of Pioneering St ...

  • 30 Jul 2019

    NanoString Technologies and Mayo Clinic Laboratories Enter Joint Developmen ...

  • 18 Jul 2019

    Inivata announces launch of clinical trial to evaluate impact of InVisionFi ...

  • 16 Jul 2019

    Inivata Signs Distribution Agreement with IPS Genomix for InVision® Genomic ...

  • 15 Jul 2019

    NanoString Collaborates with MODEL-AD Consortium to Accelerate Alzheimer’s ...

  • 10 Jun 2019

    MDxHealth (R): Multi-center Study Validates SelectMDx's High Negative Predi ...

  • 1 Jun 2019

    Caris Life Sciences Showcases Results from Novel Machine Learning Approach ...

  • 30 May 2019

    Caris Life Sciences Partners with Debiopharm International SA to Develop Co ...

  • 30 May 2019

    Caris Life Sciences Partners with Debiopharm International SA to Develop Co ...

  • 3 May 2019

    Caris Life Sciences Receives FDA Breakthrough Device Designation for MI Tra ...

  • 18 Mar 2019

    MDxHealth (R): MDxHealth Announces Positive Data from Pan-European Clinical ...

  • 7 Mar 2019

    Inivata Publishes Positive Results of Clinical Validation and Utility Study ...

  • 5 Mar 2019

    Inivata Receives Medicare Final Coverage Decision for InVisionFirst-Lung Li ...

  • 5 Mar 2019

    MDxHealth : SelectMDx® Liquid Biopsy Test for Prostate Cancer Included in t ...

  • 5 Feb 2019

    Caris Life Sciences Launches Whole Transcriptome Sequencing (WTS) with Nove ...

  • 24 Jan 2019

    MDxHealth (R): SelectMDx Outperforms Prostate Health Index (phi) Blood Test ...

  • 19 Dec 2018

    United Kingdom’s National Institute for Health and Care Excellence (NICE) R ...

  • 26 Nov 2018

    MDxHealth (R): MDxHealth Announces Approval for SelectMDx for Prostate Canc ...

  • 12 Dec 2016

    Prosigna Breast Cancer Assay Outperforms All Other Commercial Assays Tested ...

  • 5 Dec 2016

    NanoString Technologies Highlights Presentation of Multiple Prosigna/PAM50 ...

  • 6 Oct 2016

    Caris Life Sciences to Present Key Research Findings at the European Societ ...

  • 29 Aug 2016

    Caris Life Sciences Announces Major Milestone of 100,000 Clinical Cases usi ...

  • 8 Aug 2016

    Memorial Healthcare System Joins the Caris Centers of Excellence for Precis ...

  • 1 Aug 2016

    Caris Life Sciences Designates USC Norris Comprehensive Cancer Center A Car ...

  • 25 Jul 2016

    Caris Life Sciences Designates the Cancer Therapy & Research Center a Caris ...

  • 7 Jun 2016

    Caris Life Sciences Introduces Research Showing Time-To-Next Treatment as E ...

  • 2 Jun 2016

    NanoString Technologies Highlights Advances in Precision Oncology and Immun ...

  • 31 May 2016

    Caris Life Sciences to Present Key Research Findings at the 2016 American S ...

  • 26 May 2016

    Cigna Issues Positive Coverage Decision for NanoString's Prosigna® Breast C ...

  • 9 May 2016

    Aetna Issues Positive Coverage Decision for NanoString's Prosigna® Breast C ...

  • 11 Apr 2016

    Caris Life Sciences to Present Key Research Findings at the American Associ ...

  • 15 Mar 2016

    Caris Life Sciences to Present Molecular Insights Informing Treatment Strat ...

  • 14 Mar 2016

    Caris Life Sciences Announces Publication of Study Showing Nine-Month Overa ...

  • 29 Feb 2016

    NanoString Technologies and Merck Expand Collaboration to Develop and Comme ...

  • 9 Feb 2016

    American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Re ...

  • 21 Jan 2016

    Caris Life Sciences to Present Data on Clinical Benefit of Caris Molecular ...

  • 7 Jan 2016

    Caris Life Sciences to Present Research Supporting Clinical Utility of Cari ...

  • 9 Dec 2015

    Caris Life Sciences Research Yields New Molecular Insights into Rare Breast ...

  • 7 Dec 2015

    NanoString Technologies Announces Eleven Prosigna/PAM50 Presentations at th ...

  • 4 Dec 2015

    Caris Life Sciences® and Fox Chase Cancer Center – Temple Health Collaborat ...

  • 17 Nov 2015

    Caris Life Sciences to Present Research Supporting the Benefit of Precision ...

  • 28 Sep 2015

    Clinical Validity of Molecular Profiling from Caris Life Sciences Confirmed ...

  • 28 Sep 2015

    Caris Molecular Intelligence Tumor Profiling Identifies Potential Responder ...

  • 28 Sep 2015

    New Clinical Data Demonstrate Clinical Utility of Caris Molecular Intellige ...

  • 16 Sep 2015

    North Shore Hematology Oncology Associates Joins the Caris Centers of Excel ...

  • 10 Jun 2015

    Caris Life Sciences Designates Fox Chase Cancer Center a Caris Center of Ex ...

  • 31 May 2015

    Caris Life Sciences Presents New Tumor Profiling Research Providing Insight ...

  • 30 May 2015

    Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and C ...

  • 30 May 2015

    Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Com ...

  • 29 May 2015

    Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted ...

  • 29 May 2015

    Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clin ...

  • 28 May 2015

    Caris Life Sciences Presents Large Cohort Biomarker Analyses that Character ...

  • 28 May 2015

    Caris Molecular Intelligence Identifies Targeted Treatment Options for Pati ...

  • 14 May 2015

    Caris Life Sciences Announces Presentation of Comprehensive Tumor Profiling ...

  • 13 May 2015

    Caris Life Sciences Establishes the Caris Centers of Excellence for Precisi ...

  • 4 May 2015

    Caris Life Sciences Designates MedStar Health a Caris Center of Excellence

  • 13 Apr 2015

    Caris Life Sciences Vice Chairman Dr. Jonathan Knowles to Receive Personali ...

  • 7 Apr 2015

    Caris Life Sciences and COTA Enter Collaboration to Measure Clinical and Ec ...

  • 30 Mar 2015

    Caris Life Sciences’ Multiplatform Tumor Profiling Enhances Understanding o ...

  • 29 Mar 2015

    Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles t ...

  • 29 Mar 2015

    Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles t ...

  • 29 Mar 2015

    Caris Life Sciences’ Multiplatform Tumor Profiling Technology Identifies Ex ...

  • 29 Mar 2015

    Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Iden ...

  • 27 Mar 2015

    Caris Life Sciences Demonstrates Clinical Utility of Tumor Profiling by Ide ...

  • 23 Mar 2015

    Caris Life Sciences Announces Presentation of Comprehensive Tumor Profiling ...

  • 18 Mar 2015

    NanoString Technologies' Prosigna Breast Cancer Assay Included in German Br ...

  • 26 Feb 2015

    Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with ...

  • 26 Feb 2015

    Caris Life Sciences’ Multiplatform Tumor Profiling Helps to Identify Potent ...

  • 18 Feb 2015

    Caris Life Sciences Reports Record-Setting 2014 Year-End Results

  • 10 Feb 2015

    NanoString Technologies to Release Fourth Quarter 2014 Financial Results an ...

  • 4 Feb 2015

    West Cancer Center Designated a Center of Excellence by Caris Life Sciences ...

  • 28 Jan 2015

    NanoString Technologies to Present at 2015 Leerink Global Healthcare Confer ...

  • 20 Jan 2015

    Caris Life Sciences® Establishes the Caris Centers of Excellence for Precis ...

  • 16 Jan 2015

    Caris Molecular Intelligence™ Identifies Therapeutic Options, Including Nov ...

  • 15 Jan 2015

    Multiplatform Tumor Profiling from Caris Molecular Intelligence™ Identifies ...

  • 15 Jan 2015

    Caris Life Sciences’ Multiplatform Tumor Profiling of Hepatocellular and Bi ...

  • 8 Jan 2015

    NanoString Technologies Provides Update on 2014 Operational and Preliminary ...

  • 22 Dec 2014

    NanoString Technologies to Present at J.P. Morgan 33rd Annual Healthcare Co ...

  • 15 Dec 2014

    NanoString Technologies Highlights Important Results from Prosigna Decision ...

  • 11 Dec 2014

    Caris Life Sciences® Presents Two Studies Demonstrating Utility of Tumor Pr ...

  • 8 Dec 2014

    NanoString Technologies Updates Prosigna FDA Labeling to Provide Greater In ...

  • 12 Nov 2014

    Caris Life Sciences Study Shows Molecular Profiling May Expand Use of PD-1 ...

  • 30 Oct 2014

    Large Studies Show Caris Molecular Intelligence™ Identifies Targets with Th ...

  • 21 Oct 2014

    NanoString Announces Publication in the Journal of Clinical Oncology Showin ...

  • 6 Oct 2014

    NanoString Collaborates with Brigham and Women's Hospital in Boston to Acce ...

  • 2 Oct 2014

    Number of Actionable Biomarkers in Urothelial Carcinoma (UC)

  • 29 Sep 2014

    Tumour Profiling with Caris Molecular Intelligence Offers Hope For Patients ...

  • 17 Sep 2014

    Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in ...

  • 27 Aug 2014

    NanoString Announces Unexpected Death of Chief Medical Officer, J. Wayne Co ...

  • 21 Aug 2014

    NanoString Technologies to Present at Upcoming Investor Conferences

  • 14 Aug 2014

    Caris Life Sciences Collaborates with GenoSpace to Enhance Data Mining Capa ...

  • 12 Aug 2014

    Feist-Weiller Cancer Center Partners With Caris Life Sciences to Establish ...

  • 5 Aug 2014

    Caris Molecular Intelligence™ Identifies Key Biomarkers of Clinical Benefit ...

  • 5 Aug 2014

    NanoString Technologies Receives Market Approval From the Australian Therap ...

  • 29 Jul 2014

    NanoString Technologies Introduces New Universal Junction Probe Design for ...

  • 24 Jun 2014

    Valley Medical Oncology Consultants Partners With Caris Life Sciences to Es ...

  • 11 Jun 2014

    NanoString Technologies to Participate in the JMP Securities Healthcare Con ...

  • 10 Jun 2014

    Caris Life Sciences Research Provides Key Clinical Insights on Immunotherap ...

  • 5 Jun 2014

    Caris Life Sciences Presents Ground-breaking Registry Data Demonstrating Ca ...

  • 3 Jun 2014

    Caris Life Sciences Biomarker Research Suggests Role for Immune-targeted Th ...

  • 3 Jun 2014

    NanoString Technologies Enters into Biomarker Companion Diagnostic Collabor ...

  • 2 Jun 2014

    Caris Life Sciences Comprehensive Tumor Profiling Research Reveals Numerous ...

  • 31 May 2014

    Caris Life Sciences Presents Data Highlighting Utility of Multi-Technology ...

  • 30 May 2014

    Caris Life Sciences Presents ASCO Molecular Profiling Data Identifying Addi ...

  • 29 May 2014

    NanoString Technologies to Participate in the Jefferies 2014 Global Healthc ...

  • 14 May 2014

    Caris Life Sciences Advances Precision Medicine for Cancer Patients through ...

  • 6 May 2014

    NanoString Technologies Receives Canadian Market Approval for its Prosigna ...

  • 1 May 2014

    NanoString Technologies to Participate in the 2014 Bank of America Merrill ...

  • 1 Apr 2014

    Boston Business Journal Letter to the Editor: Cancer Patients Deserve to Kn ...

  • 28 Mar 2014

    Caris Life Sciences Significantly Enhances Clinical Utility of World’s Lead ...

  • 13 Mar 2014

    Newly Published Analytical Validation Study Shows Precision and Reproducibi ...

  • 19 Feb 2014

    NanoString Technologies to Participate in the Cowen 34th Annual Health Care ...

  • 14 Feb 2014

    North Shore Hematology Oncology Associates Partners With Caris Life Science ...

  • 12 Feb 2014

    Study Confirms Ability of the Prosigna Assay to Assess Risk of Late Distant ...

  • 11 Feb 2014

    NanoString Technologies Launches Commercial Reagents to Enable Laboratories ...

  • 30 Jan 2014

    Multi-Platform Tumor Profiling Research in Bladder and Prostate Cancers Yie ...

  • 29 Jan 2014

    NanoString Technologies to Participate in the Leerink Swann Global Healthca ...

  • 18 Jan 2014

    Large International Tumor Profiling Study of Colorectal Cancer Provides Key ...

  • 17 Jan 2014

    Multi-Platform Tumor Profiling Identifies Actionable Drug Targets, Potentia ...

  • 16 Jan 2014

    Tumor Profiling Studies on Difficult-to-Treat Gastrointestinal Cancers Aid ...

  • 6 Jan 2014

    NanoString Technologies to Present at the JP Morgan 32nd Annual Healthcare ...

  • 15 Feb 2003

    Caris Life Sciences’ Multiplatform Tumor Profiling Enhances Understanding o ...